ArticleTherapeutic advances in musculoskeletal disease2022

Tofacitinib as an alternative therapy for refractory intestinal Behçet's syndrome.

Jun Zou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.